Are there any contraindications or precautions dermatologists should consider before beginning a patient on ruxolitinib for vitiligo?
Featuring Benjamin Lockshin, MD |
EVP of Strategic Initiatives
Director of the Clinical Trials Center
Assistant Professor
US Dermatology Partners
Georgetown University
Rockville, MD
Related CME
Related Media
Powered by Polaris TM